Detalhe da pesquisa
1.
Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report.
J Clin Immunol
; 43(7): 1597-1602, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37306896
2.
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trial.
J Appl Clin Med Phys
; 22(1): 242-250, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33389825
3.
BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease.
Int J Mol Sci
; 20(18)2019 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31514450
4.
Treatment Strategies for Glioblastoma in the Elderly: What Should We Focus on Compared to Younger Patients.
Cancers (Basel)
; 16(6)2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539563
5.
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.
Nat Commun
; 15(1): 4210, 2024 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38806504
6.
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.
Neurooncol Adv
; 5(1): vdad105, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37811538
7.
Telemedicine in Neuro-Oncology-An Evaluation of Remote Consultations during the COVID-19 Pandemic.
Cancers (Basel)
; 15(16)2023 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627083
8.
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma.
J Cancer Res Clin Oncol
; 149(7): 3513-3526, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953681
9.
BRMS1 in Gliomas-An Expression Analysis.
Cancers (Basel)
; 15(11)2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296870
10.
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma.
Neurooncol Adv
; 5(1): vdad090, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37547266
11.
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma.
Neurooncol Adv
; 4(1): vdac137, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36284931
12.
Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma.
Front Oncol
; 11: 637185, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33937037
13.
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.
J Cancer Res Clin Oncol
; 146(3): 787-792, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828428